Intermittent Fasting May Reduce Risk of Type-2 Diabetes
A new study in Nature Medicine shows that a time-restricted, intermittent fasting diet lowered the risk of diabetes more than a reduced-calorie diet.
A new study in Nature Medicine shows that a time-restricted, intermittent fasting diet lowered the risk of diabetes more than a reduced-calorie diet.
A large body of evidence supports the use of very low-carbohydrate ketogenic diets for weight loss, reversing metabolic syndrome, putting type 2 diabetes into remission, and improving a long list of other issues. And while most individuals who adopt this way of eating experience a decrease in total cholesterol andRead
Three recent fasting studies lend clarity to the timing of fasting for weight loss and benefits of fasting diets for breast cancer patients. Let’s look first at the timing question. STUDY ONE/ A study, in Cell Metabolism, compared the timing of two daily fasting diets, also known as time-restricted feedingRead
Researchers in Australia have used state-of-the-art analytical tools to understand how intermittent fasting works on liver enzymes to help prevent disease. The findings will help medical scientists working in cancer, cardiovascular and diabetes research develop new interventions to lower disease risk and discover the optimum intervals for fasting. In experimentsRead
Does fasting work to stave off metabolic syndrome, which affects nearly 30 percent of the U.S. population, and increases the risk for type 2 diabetes, heart disease and stroke? In a collaborative effort, researchers from the Salk Institute and the UC San Diego School of Medicine, published in Cell Metabolism,Read
Researchers have discovered that meal timing strategies such as intermittent fasting or eating earlier in the daytime appear to help people lose weight by lowering appetite rather than burning more calories, according to a report published in the journal Obesity. The study is the first to show how meal timingRead
Cognitive decline is one of the most severe type 2 diabetes complications. Intermittent fasting (IF) is a promising dietary intervention for T2D risk reduction, but its protective effect and mechanism on diabetic cognitive dysfunction remain elusive. Gut microbiota plays a vital role interphasing diet and host physiology and pathology andRead